HilleVax (HLVX) announced the appointment of Sean McLoughlin as Chief Operating Officer. As part of a planned transition in connection with McLoughlin’s appointment, Co-founder and current Chief Operating Officer Dr. Aditya Kohli will remain a full-time executive with the company as Chief Business Officer, where he will be responsible for business development and corporate strategy. McLoughlin has three decades of commercial and operational experience in vaccines, most recently as the Global Vaccine Commercialization Lead, RSV at GSK (GSK).
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on HLVX:
- HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating Officer
- HilleVax, Kangh announce exclusive license agreement for HIL-216
- HilleVax to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- HilleVax initiated with bullish view at H.C. Wainwright, here’s why